Vanderbilt-Ingram Cancer Center — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center has participated in 636 clinical trials with 101 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, Children's Oncology Group, Karyopharm Therapeutics Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

• Vanderbilt University Medical Center Diagnostic Lab- Site Number : 840049
• 10-20 Vanderbilt University Medical Center
• Monroe Carell Jr Children's Hospital at Vanderbilt
• Vanderbilt University Medical Center Clinical Research Center
• Vanderbilt University Medical Center /ID# 204231
• Vanderbilt University Medical Center-GCRC
• GI Clinical Research; Vanderbilt University Medical Center
• Vanderbilt University Medical Center /ID# 164607
• The Children's Hospital at TriStar Centennial Medical Center
• Vanderbilt University Medical Center; Multiple Sclerosis Center
• Monroe Carrell Jr Children's Hospital at Vanderbilt
• Vanderbilt University ASAP Research

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center?

Vanderbilt-Ingram Cancer Center has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center conducted?

Vanderbilt-Ingram Cancer Center has 636 clinical trials on record, with 101 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Vanderbilt-Ingram Cancer Center accredited by Crixeo Clinical Trials?

Vanderbilt-Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.